Searched for malaria.

1. In vitro antiplasmodial activity and cytotoxicity of ethnobotanically selected Ivorian plants (Publications)

   In vitro antiplasmodial activity and cytotoxicity of ethnobotanically selected Ivorian plants

   Relevance:

   Eight extracts from four Ivorian medicinal plants, traditionally used to treat malaria, were tested for their antiplasmodial activity in vitro by assessing their ability to inhibit the uptake of [3H]h

2. Synthesis of 3-azabicyclo[3.2.2]nonanes and their antiprotozoal activities (Publications)

   Synthesis of 3-azabicyclo[3.2.2]nonanes and their antiprotozoal activities

   Relevance:

   The new compounds were tested for their activities against one strain of the causative organism of Malaria tropica, Plasmodium falciparum K1, which is resistant against chloroquine and pyrimethamine. In addition

3. Quest for a potent antimalarial drug lead: synthesis and evaluation of 6,7-dimethoxyquinazoline-2,4-diamines (Publications)

   Quest for a potent antimalarial drug lead: synthesis and evaluation of 6,7-dimethoxyquinazoline-2,4-diamines

   Relevance:

   activities that make them suitable for use in treating hypertension, viral infections, tumors, and malaria. Since 2014, we have synthesized approximately 150 different 6,7-dimethoxyquinazoline-2,4-diamines

4. Epidemiology of community-onset bloodstream infections in Bouaké, central Côte d'Ivoire (Publications)

   Epidemiology of community-onset bloodstream infections in Bouaké, central Côte d'Ivoire

   Relevance:

   and symptoms were not significantly associated with blood culture positivity after controlling for malaria.

5. Epidemiology of community-onset bloodstream infections in Bouaké, central Côte d'Ivoire (Publications)

   Epidemiology of community-onset bloodstream infections in Bouaké, central Côte d'Ivoire

   Relevance:

   and symptoms were not significantly associated with blood culture positivity after controlling for malaria.

6. In vitro antiplasmodial activity and cytotoxicity of ethnobotanically selected Ivorian plants (Publications)

   In vitro antiplasmodial activity and cytotoxicity of ethnobotanically selected Ivorian plants

   Relevance:

   Eight extracts from four Ivorian medicinal plants, traditionally used to treat malaria, were tested for their antiplasmodial activity in vitro by assessing their ability to inhibit the uptake of [3H]h

7. Quest for a potent antimalarial drug lead: synthesis and evaluation of 6,7-dimethoxyquinazoline-2,4-diamines (Publications)

   Quest for a potent antimalarial drug lead: synthesis and evaluation of 6,7-dimethoxyquinazoline-2,4-diamines

   Relevance:

   activities that make them suitable for use in treating hypertension, viral infections, tumors, and malaria. Since 2014, we have synthesized approximately 150 different 6,7-dimethoxyquinazoline-2,4-diamines

8. Co-infection of <em>Plasmodium knowlesi</em> and <em>Plasmodium vivax</em>: a rare clinical encounter in a traveller returning to Switzerland (Publications)

   Co-infection of <em>Plasmodium knowlesi</em> and <em>Plasmodium vivax</em>: a rare clinical encounter in a traveller returning to Switzerland

   Relevance:

   Malaria caused by Plasmodium knowlesi presents a notable diagnostic hurdle due to its shared morphological similarities with other Plasmodium species, complicating identification. The diagnosis can further

9. Synthesis of 3-azabicyclo[3.2.2]nonanes and their antiprotozoal activities (Publications)

   Synthesis of 3-azabicyclo[3.2.2]nonanes and their antiprotozoal activities

   Relevance:

   The new compounds were tested for their activities against one strain of the causative organism of Malaria tropica, Plasmodium falciparum K1, which is resistant against chloroquine and pyrimethamine. In addition

10. Mar Velarde (People)

    Mar Velarde

    Relevance:
    https://www.swisstph.ch/en/staff/profile/people/mar-velarde

    worked for two different departments within the World Health Organization (WHO), namely the Global Malaria Programme and the Department of Neglected Tropical Diseases. Since 2018, Mar has been working at